Imagine carrying a condition that could silently threaten your life and your baby's, only to be repeatedly told you're not at risk. This is the terrifying reality for many women facing a potentially fatal childbirth complication, and a new campaign is demanding the NHS do better.
Amisha Adhia is spearheading a vital initiative, urging the National Health Service (NHS) to enhance the diagnosis of a rare but life-threatening condition related to childbirth. Her personal harrowing experience, where five different hospitals failed to identify a serious complication, has ignited this powerful campaign.
What is Placenta Accreta Spectrum (PAS)?
Simply put, PAS occurs when the placenta, which is the lifeline for your baby during pregnancy, attaches itself too deeply into the uterine wall. Instead of detaching naturally after birth, it can become stuck, leading to severe complications. Think of it like a root growing too deeply into the soil – it's hard to remove without causing damage.
Who is Most at Risk?
While PAS can affect any pregnant woman, the risk significantly increases for those who have previously given birth via caesarean section or have undergone IVF treatment. The increasing rates of C-sections in England, now outnumbering vaginal births, mean that more women are potentially at greater risk than ever before.
The Danger of Missed Diagnosis
If PAS isn't identified before labor begins, the consequences can be dire. Women can face emergency hysterectomy (removal of the uterus) or, in the worst-case scenario, bleeding to death from a severe hemorrhage. This is precisely why early and accurate diagnosis is so crucial.
Amisha's Story: A Wake-Up Call
Amisha Adhia was repeatedly assured by medical professionals at five London hospitals that she did not have PAS, despite her concerns. She was told her placenta was positioned too high to be a risk. However, a sharp-eyed consultant obstetrician, Dr. Chineze Otigbah, recognized the danger and intervened, ensuring Amisha received the necessary care when she gave birth to her daughter, Ishaani. Amisha recounted her terrifying experience, stating, "I was reassured into danger. I was carrying a condition that could have killed us both. I felt unheard. I thought I was going to die."
But here's where it gets controversial... Amisha felt her concerns were dismissed, leading to her feeling "assessed, downgraded and ignored." This sentiment highlights a critical issue: are women's instincts and concerns being adequately heard and acted upon within the NHS maternity system?
The Scale of the Problem
It's estimated that between 1 in 300 and 1 in 2,000 women develop PAS. However, the exact figures are difficult to ascertain because the NHS does not systematically record data on this condition. Studies from other countries, like the US and Israel, suggest the prevalence could be as high as 1 in 111 pregnant women. This lack of data makes it challenging to truly understand the scope of the problem and allocate resources effectively.
A Call for Action
Amisha and her husband, Nik, have launched the Action for Accreta campaign to raise awareness and push for change. They have been contacted by around 40 women who have faced similar setbacks due to undiagnosed PAS. Eight prominent baby and maternal health groups have lent their support to the campaign, emphasizing the need for improved awareness, surveillance, and learning regarding serious pregnancy complications.
And this is the part most people miss... The Royal College of Obstetricians and Gynaecologists (RCOG) acknowledges that PAS is associated with high maternal and neonatal morbidity and mortality, and that rates are increasing due to rising C-section rates, later average maternal age, and increased use of assisted reproductive technologies. Yet, Amisha's experience suggests that current diagnostic practices may not be keeping pace with these evolving risks.
What's Being Done?
The Adhias have presented their evidence to an inquiry into maternity care in England, urging for recommendations to improve PAS identification. Dr. Otigbah expressed deep concern, stating, "The NHS has not kept up to date with this reality. Not every hospital has PAS specialists, so subtle warning signs can be overlooked."
The RCOG is currently updating its guidance, and Amisha and Nik hope it will include specific advice on diagnosing and managing atypical forms of PAS, like the one Amisha experienced. They are also looking to the NHS to improve its specialist training and diagnostic capabilities.
What do you think? Given the rising rates of C-sections and IVF, do you believe the NHS is adequately prepared to diagnose and manage conditions like placenta accreta spectrum? Share your thoughts and experiences in the comments below – let's discuss!
